SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193805-04-000194
Filing Date
2004-02-05
Accepted
2004-02-05 17:23:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G e400090_sc13g-lynx.txt SC 13G/A 8897
  Complete submission text file 0001193805-04-000194.txt   10689
Mailing Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545
Business Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Subject) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45671 | Film No.: 04570911
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address C/O FIRST NEW YORK SECURITIES, LLC 850 THIRD AVENUE, 8TH FLOOR NEW YORK NY 10022
Business Address
EDELMAN JOSEPH (Filed by) CIK: 0001164426 (see all company filings)